by milena henderson | May 18, 2026 | Non classé, Quality & Business Excellence
Last month, Pharmalys had the privilege of participating in the OneWe Reach Global Conversations & Connections Summit in Accra, Ghana, a gathering that brought together African and global leaders committed to shaping the future of health innovation across the...
by milena henderson | Apr 20, 2026 | Quality & Business Excellence
Pharmalys’ approach to corporate social responsibility reflects its long-standing commitment to advancing clinical research while contributing to sustainable and inclusive healthcare systems, particularly across the African continent. Structured around three core...
by milena henderson | Apr 20, 2026 | Non classé, Quality & Business Excellence
On 26 March 26 2026, Pharmalys held its first Pharmalys Voice meeting of the year, bringing together colleagues from across the company for an engaging and interactive virtual session. With a mix of insightful presentations, lively discussions and moments of fun, the...
by Veronique Ropion | Mar 24, 2026 | Quality & Business Excellence
Pharmalys is an international Clinical Research Organisation (CRO) with a diverse team distributed across Europe, Asia, North America and Africa. Within our global portfolio, we support the execution of numerous clinical trials (CTs) in Africa. Across these projects,...
by milena henderson | Mar 19, 2026 | GCLP Accreditation Scheme, Quality & Business Excellence
On Friday 13 March 2026, Jeanette Young, Laboratory Solutions & GCLP Team Lead at Pharmalys, delivered an insightful and engaging presentation at TASK HQ in South Africa. TASK is a global clinical research organisation with an in-house laboratory currently...
by milena henderson | Mar 16, 2026 | Quality & Business Excellence
At Pharmalys, Quality is more than just a word – it is our promise. Quality can be defined as the standard of something as measured against other things of a similar kind, or the degree of excellence achieved. In clinical research, Quality ensures that clinical...
